in a greater likelihood of left upper lobe obstruction occurring before the tracheal lumen orifice disappeared into the left main bronchus. This might have alerted us to the impending problem.
The complication seen in our patient may have been avoided if we had used a right-sided double-lumen endobronchial tube but this is usually associated with more problems in accurate placement. 9 Several authors have recommended fibreoptic bronchoscopy through the tracheal lumen to confirm the position of the double-lumen tube. ',9 This may have been useful in our patient at induction but we suspect that the tube became displaced during the course of the operation.
In summary, we present a case in which doublelumen endobronchial tube displacement during twolung ventilation occluded the gas flow to the right lung and resulted in frank left unilateral pulmonary oedema. The onset was sudden, with rapid arterial oxygen desaturation; pulmonary oedema resolved immediately after replacement of the double-lumen endobronchial tube with a single-lumen endotracheal tube. We propose that the displacement resulted in right lung hypoxic pulmonary vasoconstriction which diverted blood to the abnormal left lung, causing left-sided pulmonary oedema. We suggest that the different distances between the lumen orifices in Mallinckrodt and Robertshaw tubes would make the former more prone to displacement during thoracotomy.
The practice of cardiothoracic surgery and anaesthesia has become an area where technology has progressed rapidly, and this is especially so in the field of cardiac transplantation. The concept of bridging patients with end stage dilated cardiomyopathy to transplant with mechanical ventricular assist devices (VADs) has moved from futuristic thought to practicality. In the area of intra-operative monitoring, two-dimensional transoesophageal echocardiography (TOE) presents a new noninvasive approach to moni-to ring many aspects of cardiac function, It also enables excellent visualisation of intracardiac structures, A case is described where these new technologies were critical in the management of a patient with end stage cardiac failure,
CASE REPORT
A 16-year-old, 60 kg male student was referred to our unit for consideration of cardiac transplantation. He had a two-month history of deteriorating exercise tolerance, and was found to have endstage idiopathic dilated cardiomyopathy, with a left ventricle (LV) ejection fraction of 7ff!o despite optimal medical therapy, At that time pulmonary artery catheterisation showed a cardiac index (Cl) of 1.85 l.min I.m -2, normal pulmonary vascular resistance and trans-pulmonary gradient (TPG=[mean PAP-PCWPD of 5 mmHg.
One week later he was readmitted because of clinical deterioration. A dopamine infusion was commenced at 3 mcg.kg -I.m -I with little improvement. Repeat pulmonary artery catheterisation showed a markedly elevated PCWP of 35 mmHg and a Cl of 1.03 I.min -I.m -2. Blood gas analysis demonstrated a compensated metabolic acidosis (pH 7.49, P a C02 24 mmHg, HC03 19 mmol.l-I and serum lactate 6.9 mmol.l-I ). Other biochemistry showed marked hepatic impairment, with AST 1530 U.l-I , ALT 2670 U.l-I and LDH 2000 U.l-I . An infusion of adrenaline was commenced (5 j.tg.min -I) without significant improvement in his haemodynamics, so he was considered for mechanical circulatory support.
After transfer to theatre, arterial and central venous cannulations were also performed. Haemodynamic measurements showed little improvement despite alteration of adrenaline dose (up to 10 j.tg.min -I), and addition of sodium nitroprusside (1 j.tg.kg-I.m -I). The decision was made to use a volume displacement left ventricular assist device (LVAD), the "Thoratec" (Thoratec Corp, Berkeley, CA, USA), as it was felt the intra-aortic balloon pump (IABP) would be unlikely to improve his haemodynamics.
Anaesthesia was induced and maintained with fentanyl (total dose 55 j.tg.kg-I ), diazepam (total dose 0.4 mg.kg-I ); tracheal intubation was facilitated with pancuronium 0.2 mg.kg-I and the lungs ventilated with 100070 oxygen.
The TOE probe was inserted, and an echocardiographic study performed. This revealed severe biventricular dysfunction with marked dilatation of both chambers, and a small apical LV thrombus. An echocontrast injection (microbubbles produced by agitation of a saline-filled syringe) during a valsalva manoeuvre showed no evidence of a patent foramen ovale. Mild mitral regurgitation was also present.
Because of the necessary heart manipulation, insertion of the LV AD was performed with the patient on cardiopulmonary bypass (CPB). The LV apex was not used for cannula insertion because of the thrombus seen on TOE. The "Thoratec" inflow and outflow cannulae were inserted into the left atrium (LA) and ascending aorta, respectively. After appropriate deairing, the patient was weaned slowly from CPB (time = 123 min), with the "Thoratec" pumping at 4 l.min -I. Initial pharmacological support consisted of adrenaline 2 j.tg.min-I , dopamine 3 j.tg.kg-I.min-I and sodium nitroprusside 0.4 j.tg.kg -I.min -I .
Following bypass the patient's haemodynamic indices were Cl 2.5 l.min -I.m -2, BP 110nO mmHg, RAP 9 mmHg, PAP 25/15 mmHg and PCWP 12 mmHg. Following a long period of observation no deterioration in right heart function was noted. The bypass cannulae were removed and the adrenaline infusion was ceased.
At this stage a further TOE study was performed, which showed correct positioning of the inflow cannula in the mid LA, minimal native LV contraction, and no change in position and size of the LV thrombus.
With continuing improvement in haemodynamics and decreasing inotrope requirements, the sternum was closed and the patient transferred to the ICU. He was weaned from the ventilator and vasoactive infusions (nitroprusside and low-dose dopamine) over the following 48 hours. A low-dose heparin infusion (1000 U.hr-I ) was continued to maintain the activated clotting time between 180 and 200 seconds.
He remained stable on mechanical support. On the seventh postoperative day he developed acute left upper abdominal pain and a dense left hemiplegia. CT scan of the abdomen demonstrated multiple splenic infarcts and CT scan of the head showed oedema in the middle cerebral artery territory without any infarction. His heparin dose was increased immediately as it was thought the most likely aetiology was embolism from either of his "hearts". His neurological deficit slowly resolved during the day.
A trans-thoracic echocardiogram (TTE) was performed to define the source of his emboli. This showed the small thrombus still at the LV apex (unchanged) and the presence of ill-defined echoes in the region of the left atrial appendage, which may have been new thrombus. It was then vital to evaluate the LA more completely so a TOE was performed. This demonstrated the LA to be clear of thrombus, the drainage and return cannulae in good position, spontaneous contrast in the LV consistent with very low flow, and non-opening of the aortic and mitral valves. In addition, there was a moderate pericardial effusion, with probable organised thrombus superior to the LA, matching the appearance on the TTE.
It was felt that the emboli probably originated in the native LV, secondary to the very low flow, despite heparin therapy. After his neurological condition improved he was placed on the active transplant waiting list.
Two days later a suitable donor heart became available. After nine days and 18 hours of mechanical support, orthotopic cardiac transplantation was performed. He was weaned from bypass without problem, requiring routine infusions of renal-dose dopamine and isoprenaline. His postoperative course was uneventful; he has subsequently made an excellent recovery, and is now back playing football and studying at school.
DISCUSSION

Ventricular Assist Devices
The idea of mechanical replacement or temporary mechanical support of the failing heart has been with us for some time now. These devices vary in physiological sophistication from the IABP through to artificial ventricles providing an almost normal, pulsatile arterial pressure profile (Table 1) . The "Thoratec" (formerly Pierce-Donachy) VAD consists of a prosthetic ventricle, with a stroke volume of 65 ml, appropriate cannulae for connection between patient and device, and a pneumatic drive console. It is theoretically capable of generating cardiac outputs of the order of 7 to 8 l.min -I. Up until the time of writing, our unit has used the "Thoratec" on a further eleven patients with 280 days cumulative support.
Transoesophageal Echocardiography
The management and monitoring of patients during insertion of a VAD and with the device in situ is enhanced by echocardiography. I.' By directly visualising intracardiac structures, entities that may cause problems during and after insertion can be identified. The presence of intracavity thrombi obviously necessitates extra care during cannulation due to the risk of embolism. Abnormal communications between chambers, such as patent foramen ovale, can lead to right-to-Ieft shunting and dangerous hypoxaemia when the device starts pumping. J Application of colour-coded Doppler allows demonstration of the direction and velocity of blood flow through such communications as well as across valves. The correct positioning of either the device itself or connecting cannulae can be verified, ensuring correct drainage from cardiac chambers. 4 Intracardiac air can be identified. We are able to monitor the response of both ventricles to the assistance provided by the device, and with repeat studies assess either progression of the disease process or recovery of native cardiac function. 2 This greatly facilitates device weaning.
For intraoperative echocardiography, the two approaches that are currently available are epicardial and transoesophageal. Historically, epicardial echocardiography has been the standard, but more recently TOE has become increasingly popular. '.6 Epicardial echocardiography has a number of disadvantages. A sterile sheath must be used and the probe applied directly to the heart, thus interrupting surgery and, by implication, limiting imaging time. The pressure of the transducer on the heart may potentially produce arrhythmias or damage the cardiac tissue, and of course the probe and sheath may compromise sterility. However, it does provide high-quality images, enable multiple viewing planes to be used (similar to standard TTE), and use of both pulse and continuous wave Doppler enables measurement of outflow tract and valvular gradients. In addition, the epicardial echocardiographic system and probe are easily moved from one theatre to another and can be used virtually at any stage during the operation.
TOE lends itself to intraoperative use, not only in cardiac surgery, but also in other areas. There is more time for imaging without interruption to the surgery or interference with the sterile field, and excellent visualisation of posterior structures (in particular the mitral valve and LA) is provided. The close apposition of the oesophagus and the heart, without chest wall or lung intervening, may provide more consistent, good quality images, enabling better detection of intracardiac air or thrombus. The probe may be left in situ for the duration of a case, and if appropriate, used to monitor ventricular function and myocardial ischaemia (via regional wall motion abnormalities). 9.111 Limitations of TOE intraoperatively include fewer tomographic imaging planes (although with the introduction of bi-and multi-planar probes this has become less of a problem); some limitation of imaging time due to electrocautery interference; no continuouswave Doppler and so assessment of some valve/outflow tract gradients may be suboptimal (a problem with earlier probes); and, once the patient is prepared and draped, at least for cardiac surgery, the probe can be difficult to insert. Despite these limitations, we have made it standard practice to use TOE intraoperatively during insertion of VADs in all patients.
In summary, we present a case in which sophisticated mechanical support was successfully provided to a patient with endstage cardiac pump failure, in whom the intra-and postoperative management was greatly enhanced with the use of transoesophageal echocardiography.
